Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy-Reference-Cited by-同舟云学术

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Published:2020-01 Issue:1 Volume:20 Page:53-56
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Nandakumar Bharat,Kumar Shaji K.,Dispenzieri Angela,Buadi Francis K.,Dingli David,Lacy Martha Q.,Hayman Suzanne R.,Kapoor Prashant,Leung Nelson,Fonder Amie,Hobbs Miriam,Hwa Yi Lisa,Muchtar Eli,Warsame Rahma,Kourelis Taxiarchis V.,Russell Stephen,Lust John A.,Lin Yi,Go Ronald S.,Siddiqui Mustaqeem,Zeldenrust Steven,Kyle Robert A.,Gertz Morie A.,Rajkumar S. Vincent,Gonsalves Wilson I.

Funder

National Cancer Institute

Marion Schwartz Foundation for Multiple Myeloma

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

2. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia;Blade;Hematol Oncol Clin North Am,1999

3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

4. The multiple myelomas - current concepts in cytogenetic classification and therapy;Kumar;Nat Rev Clin Oncol,2018

5. Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias;Decourt;J Leukoc Biol,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in “real-world” study: Experiences of the Polish Myeloma Group;Advances in Clinical and Experimental Medicine;2024-08-29

2. Non-Secretory Multiple Myeloma Associated With High-Risk Phenotype and Complex Cytogenetics Including t(8;22);Journal of Hematology;2024-06

3. Profile and outcome of multiple myeloma with and without HIV treated at a tertiary hospital in KwaZulu-Natal, South Africa;PLOS ONE;2023-10-25

4. Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China;BMC Cancer;2023-10-02

5. Associations between M-protein and bone marrow fibrosis in newly diagnosed multiple myeloma;Journal of Hematology and Allied Sciences;2023-03-16